Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Anti-glaucoma Medications on Pupillary Light Reflex
NCT02522039Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- May 2014
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of latanoprost, timolol and dorzolamide in Glaucoma (4 arms), sponsored by Rigshospitalet Glostrup. Primary endpoint: Post-illumination pupillary response at 1 day. Started May 2014; status: completed.
02
Drugs
latanoprosttimololdorzolamide
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02522039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522039.